Sort
48,018 grants matching “immunotherapy”
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$395,115Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2022 · CA
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$395,115Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2019 · CA
Chemo-Immunotherapy in Relapsed/Refactory B-Chronic Lymphocytic Leukemia
$395,110Neil E Kay · Mayo Clinic Rochester · R01 · FY2007 · CA
Cellular Immunotherapy of Ovarian Cancer
$395,109Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Cellular Immunotherapy of Ovarian Cancer
$395,109Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Quantitative Systems Biomedicine and Pharmacology for Multiscale Tissue Damage
$395,101Ashlee Nicole Ford Versypt · State University Of New York At Buffalo · R35 · FY2023 · GM
Discovery & Validation of Biomarkers of Kidney Pathology
$395,089Brad H Rovin · Ohio State University · U01 · FY2016 · DK
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
$395,087Gianpietro Dotti · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Role of Staphylococcus aureus alpha-hemolysin in disease
$395,039Juliane Bubeck Wardenburg · Washington University · R01 · FY2021 · AI
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
$395,014Wendell A Lim · University Of California, San Francisco · R01 · FY2024 · CA
Immunomodulatory effects of arginine supplementation in colitis and colon cancer
$395,000Keith T Wilson · Vanderbilt University Medical Center · R01 · FY2016 · AT
Vaccine Assembly from Surface Proteins of Staphylococcus Aureus
$395,000Olaf Schneewind · University Of Chicago · R01 · FY2015 · AI
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
$395,000Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · AI
An In Silico, Medical Record-based Model for Understanding the INitiation of Autoimmune Events (IMMUNE)
$395,000Theresa L Walunas · Northwestern University At Chicago · R61 · FY2019 · AR
Vaccine Assembly from Surface Proteins of Staphylococcus Aureus
$395,000Olaf Schneewind · University Of Chicago · R01 · FY2017 · AI
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
$395,000Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · AI
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$395,000Johns Hopkins University · R01 · FY2002 · CA
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
$395,000Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · AI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer
$395,000Keith T Wilson · Vanderbilt University Medical Center · R01 · FY2017 · AT
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$395,000Robert A Rissman · University Of California, San Diego · R01 · FY2021 · AG
Metabolic and purinergic immune regulation
$395,000Wolfgang G Junger · University Of California, San Diego · R35 · FY2024 · GM
Vaccine Assembly from Surface Proteins of Staphylococcus Aureus
$395,000Olaf Schneewind · University Of Chicago · R01 · FY2014 · AI
Vaccine Assembly from Surface Proteins of Staphylococcus Aureus
$395,000Olaf Schneewind · University Of Chicago · R01 · FY2016 · AI
Metabolic and purinergic immune regulation
$395,000Wolfgang G Junger · University Of California, San Diego · R35 · FY2023 · GM
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
$395,000Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · AI